Alimta drug research

The study at the Northern Institute for Cancer Research will develop tests of mesothelioma samples to find out which patients will benefit from the drug pemetrexed (Alimta) in combination with a platinum drug.

The research will help to understand why only some people with mesothelioma respond to Alimta. This will help establish at the time of diagnosis whether a patient is likely to respond or whether they should be offered an alternative treatment.

The data collected will help to identify what makes mesothelioma resistant to treatment and therefore direct new research into new drugs to treat the disease.

The research will be supervised by the Centre’s Director, Professor Hilary Calvert who led the team that develop Alimta If successful it will make the treatment more cost effective, one of the issues concerning NICE decision while giving those suffering from the illness a much better quality of life for longer.

Source - Mesothelioma research

To contact one of our specialist lawyers please call 0800 61 66 81 , or use the contact details at the top left of this page.

What our clients say about us...

"I knew immediately that I would only feel comfortable using a well-established law practice with substantial resources and experience. I called because I knew that you would take care of me and my family. You helped to get our lives back on track." Mr S Henderson, Ipswich

select this link to see how we can help...

Questions answered online within 1 hour

Specialised lawyer

Answered for free

No commitment

Find out more

Have I got a case?

Working with:

Law Society

Law Society Personal Injury

Association of Personal Injury Lawyers

Headway

Back Up Trust

Motor Accidents Solicitors Society

Investors in People

News centre

Latest News 06/01/09 In order to try and find an effective treatment and cure for mesothelioma, clinical trials have... Click to read more... A drug that could protect people from the harmful effects of inhaling asbestos fibres decades ago... Click to read more... All News

Change Text Only Settings

Graphic version of this page